CA-ESRI
24.6.2021 14:02:10 CEST | Business Wire | Press release
Esri , the global leader in location intelligence, today announced it is releasing for the first time ever a new high-resolution, 2020 global land cover map as part of the company’s Living Atlas . The map was built using European Space Agency (ESA) Sentinel-2 satellite imagery, and developed using a new machine learning workflow teaming with new Esri Silver Partner Impact Observatory , as well as long-time partner Microsoft.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210624005176/en/
The new map will be updated annually supporting change detection and highlighting planetary land changes, especially related to the effects of human activity. A consistent map of land cover for the entire world based on the most current satellite information, the 2020 Global Land Cover Map can be combined with other data layers for green infrastructure, sustainability projects, and other conservation efforts that require a holistic picture of both the human and natural footprint on the planet. Later this year, Esri and Impact Observatory will make this new land cover model available to support on-demand land cover classification, allowing the GIS community to create maps for project areas as often as every week.
"This is a critical year for climate action," said Jack Dangermond, Esri founder and president. "With the UN Climate Change Conference of the Parties (COP26) bringing international parties together to address a set of common goals, we are happy to do our part in making this map available to users that are working towards the health of our planet."
Users will also be able to manipulate the map in association with other GIS layers such as terrain, hydrology, and more, all available in ArcGIS Living Atlas of the World, the foremost collection of geographic information from around the globe, including maps, apps, and data layers. Through the visualizations being released, planners worldwide will better understand the geography around them to make more informed decisions—enabling them to gain insight into locations with distinctive land cover, as well as human activity affecting them.
High-resolution, open, accurate, comparable, and timely land cover maps are critical for decision-makers in many industry sectors and developing nations. These maps improve understanding of important topics such as food security, land use planning, hydrology modeling, and resource management planning. In addition, national government resource agencies use land cover as a basis for understanding trends in natural capital, which helps define land planning priorities and is the basis of budget allocations.
Impact Observatory, contracted by Esri, developed a deep learning AI land classification model using a massive training dataset of billions of human-labeled image pixels, and applied this model to the Sentinel-2 2020 scene collection, processing over 400,000 Earth observations to produce the map. The unique machine learning approach used to create this global map will soon be available on demand, supporting land managers who need to monitor change in a specific area of interest, looking at annual change and seasonal differences in land cover.
"Global efforts are urging world leaders to set and achieve ambitious conservation targets," said Steve Brumby, Impact Observatory co-founder and CEO. "With support from the geospatial experts at Esri, and access to incredible compute resources at Microsoft, we were able to build in record time a land cover map that provides leaders in governments, NGOs, and across industries with a novel, timely view of the planet, and a new AI-powered capability for actionable, science-based insights on demand. In doing so, Impact Observatory hopes to contribute towards the global conservation effort."
Esri is releasing this valuable resource under a Creative Commons license to encourage broad adoption and ensure equitable access for planners creating a more sustainable planet. This content will be made available in ArcGIS Online as a map service and be freely available for use by its 10 million users. It will also be available for download and viewing. To explore the new 2020 Global Land Cover Map, visit livingatlas.arcgis.com/landcover .
About Impact Observatory
Impact Observatory is a mission-driven technology company bringing artificial intelligence (AI) powered algorithms and on-demand data to sustainability and environmental risk analysis for governments, non-profit organizations, companies, and markets. Founded in 2020 in Washington, DC, Impact Observatory’s goal is to empower global decision-makers to be planetary superheroes, with the timely, actionable science-based insights they need to succeed. Visit us at impactobservatory.com .
About Esri
Esri, the global market leader in geographic information system (GIS) software, location intelligence, and mapping, helps customers unlock the full potential of data to improve operational and business results. Founded in 1969 in Redlands, California, USA, Esri software is deployed in more than 350,000 organizations globally and in over 200,000 institutions in the Americas, Asia and the Pacific, Europe, Africa, and the Middle East, including Fortune 500 companies, government agencies, nonprofits, and universities. Esri has regional offices, international distributors, and partners providing local support in over 100 countries on six continents. With its pioneering commitment to geospatial information technology, Esri engineers the most innovative solutions for digital transformation, the Internet of Things (IoT), and advanced analytics. Visit us at esri.com .
Copyright © 2021 Esri. All rights reserved. Esri, the Esri globe logo, ArcGIS, The Science of Where, esri.com, and @esri.com are trademarks, service marks, or registered marks of Esri in the United States, the European Community, or certain other jurisdictions. Other companies and products or services mentioned herein may be trademarks, service marks, or registered marks of their respective mark owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210624005176/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release
Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
